The European Cell Medicine Initiative (ECMI) is a transnational collaboration uniting leading institutions across Europe and beyond to advance personalized cell, gene, and immune therapies.

By bridging cutting-edge biomedical research with clinical application, ECMI integrates high-resolution omics data, AI-driven analysis, and harmonized regulatory frameworks.

It also serves as a global platform for strategic investment, connecting science with industry, investors, and public stakeholders to accelerate innovation in precision medicine—across Europe and worldwide.

Our Vision

To lead the global transformation of biomedical innovation into personalized, cell-based therapies by accelerating the translation of cutting-edge research into real-world clinical care—starting in Europe and reaching patients worldwide.

Our Mission

To accelerate the translation of innovative molecular and cellular research into personalized therapies by uniting leading institutions, streamlining clinical and regulatory pathways, and fostering innovation, education, and investment across Europe and globally.